Literature DB >> 3293504

Serological markers in HIV infection.

J M Lange1, J Goudsmit, F De Wolf, R A Coutinho, J van der Noordaa.   

Abstract

HIV antigenaemia can be detected at or possibly before the onset of clinical symptoms of primary HIV infection. Approximately one week after the onset of HIV antigenaemia, a primary anti-HIV IgM response may occur. A week later, generally within 3 to 6 weeks after infection, anti-HIV IgG can be detected. After primary infection, most persons enter an asymptomatic stage, often with generalized lymphadenopathy of varying duration. Disease progression is associated with the appearance of persistent HIV antigenaemia and with a decline of antibody reactivity to the viral core proteins p17 and p24.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3293504

Source DB:  PubMed          Journal:  Ann Med Interne (Paris)        ISSN: 0003-410X


  5 in total

1.  Quantitative western immunoblotting analysis in survey of human immunodeficiency virus-seropositive patients.

Authors:  D G Schiavini; J M Puel; S A Averous; J A Bazex
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

2.  High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease.

Authors:  Jörg Schüpbach; Leslie R Bisset; Stephan Regenass; Philippe Bürgisser; Meri Gorgievski; Ingrid Steffen; Corinne Andreutti; Gladys Martinetti; Cyril Shah; Sabine Yerly; Thomas Klimkait; Martin Gebhardt; Franziska Schöni-Affolter; Martin Rickenbach; J Barth; M Battegay; E Bernascon; J Böni; H C Bucher; P Bürgisser; C Burton-Jeangros; A Calmy; M Cavassini; R Dubs; M Egger; L Elzi; J Fehr; M Fischer; M Flepp; P Francioli; H Furrer; C A Fux; M Gorgievski; H Günthard; B Hasse; H H Hirsch; B Hirschel; I Hösli; C Kahlert; L Kaiser; O Keiser; C Kind; T Klimkait; H Kovari; B Ledergerber; G Martinetti; B Martinez de Tejada; N Müller; D Nadal; G Pantaleo; A Rauch; S Regenass; M Rickenbach; C Rudin; P Schmid; D Schultze; F Schöni-Affolter; J Schüpbach; R Speck; P Taffé; A Telenti; A Trkola; P Vernazza; V von Wyl; R Weber; S Yerly
Journal:  BMC Infect Dis       Date:  2011-09-26       Impact factor: 3.090

3.  Simple estimation of incident HIV infection rates in notification cohorts based on window periods of algorithms for evaluation of line-immunoassay result patterns.

Authors:  Jörg Schüpbach; Martin D Gebhardt; Alexandra U Scherrer; Leslie R Bisset; Christoph Niederhauser; Stephan Regenass; Sabine Yerly; Vincent Aubert; Franziska Suter; Stefan Pfister; Gladys Martinetti; Corinne Andreutti; Thomas Klimkait; Marcel Brandenberger; Huldrych F Günthard
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

4.  Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.

Authors:  Jörg Schüpbach; Martin D Gebhardt; Zuzana Tomasik; Christoph Niederhauser; Sabine Yerly; Philippe Bürgisser; Lukas Matter; Meri Gorgievski; Rolf Dubs; Detlev Schultze; Ingrid Steffen; Corinne Andreutti; Gladys Martinetti; Bruno Güntert; Roger Staub; Synove Daneel; Pietro Vernazza
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069

5.  Decreasing Proportion of Recent Infections among Newly Diagnosed HIV-1 Cases in Switzerland, 2008 to 2013 Based on Line-Immunoassay-Based Algorithms.

Authors:  Jörg Schüpbach; Christoph Niederhauser; Sabine Yerly; Stephan Regenass; Meri Gorgievski; Vincent Aubert; Diana Ciardo; Thomas Klimkait; Günter Dollenmaier; Corinne Andreutti; Gladys Martinetti; Marcel Brandenberger; Martin D Gebhardt
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.